Increased osteoclastic differentiation by PMMA particle-associated macrophages. Inhibitory effect by interleukin 4

A Sabokbar1, Y Fujikawa, J Brett

  • 1Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Headington, UK.

Insights

Polymethylmethacrylate (PMMA) wear particles promote macrophage differentiation into bone-resorbing osteoclasts. Interleukin 4 (IL-4) and Leukemia Inhibitory Factor (LIF) can inhibit this process, suggesting therapeutic potential.

Area of Science:

  • Biomaterials Science
  • Immunology
  • Orthopedics

Background:

  • Polymethylmethacrylate (PMMA) is widely used in orthopedic implants.
  • Wear particles from PMMA can trigger inflammatory responses.
  • Macrophage differentiation into osteoclasts contributes to bone resorption.

Purpose of the Study:

  • To investigate the effect of PMMA wear particles on macrophage-osteoclast differentiation.
  • To explore the role of Interleukin 4 (IL-4) and Leukemia Inhibitory Factor (LIF) in this process.

Main Methods:

  • Mouse monocytes were co-cultured with osteoblast-like cells (UMR 106) in the presence of 1,25 dihydroxy vitamin D3.
  • PMMA particles were added to the cultures.
  • Tartrate-resistant acid phosphatase (TRAP) expression and lacunar bone resorption were measured.
  • IL-4 and LIF, along with neutralizing antibodies, were used to assess their effects.

Main Results:

  • PMMA particles significantly increased osteoclast differentiation, evidenced by higher TRAP expression and bone resorption.
  • Addition of IL-4 and LIF markedly reduced TRAP expression and inhibited bone resorption.
  • Neutralizing antibodies to IL-4 and LIF reversed the inhibitory effects.

Conclusions:

  • PMMA wear particles enhance macrophage differentiation into osteoclasts.
  • IL-4 and LIF play a crucial role in inhibiting PMMA-induced osteoclastogenesis.
  • Targeting IL-4 and LIF pathways may offer strategies to mitigate bone loss associated with PMMA debris.